Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed May 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$156K
Net Open-Market Flow
-$156K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Sell(S)32$153.50$5K4K
May 4, 2026Sell(S)236$154.24$36K3K
May 4, 2026Sell(S)325$155.21$50K3K
May 4, 2026Sell(S)235$156.57$37K3K
May 4, 2026Sell(S)172$157.49$27K3K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-206456) within minutes of acceptance. Every field above traces to the original document. Verify it directly: